Procathepsin D Stimulation of Human Breast Cancer Cell Growth
Abstract
The long-term objective of this project is to develop a new treatment for breast cancer based on blockade of the autocrine growth factor activity of procathepsin D, the enzymatically inactive precursor of common enzyme cathepsin D. This precursor has been found to be overexpressed and actively secreted from various breast tumor cells. For this project it is important to realize that the aspartic proteinase cathepsin D is generated by removal of an activation peptide (APpCD) from the procathepsin D molecule. In past, procathepsin D has been identified as an independent prognostic factor in several forms of cancer, particularly breast cancer. m
Document Details
- Document Type
- Technical Report
- Publication Date
- Nov 01, 2002
- Accession Number
- ADA412760
Entities
People
- Vaclav Vetvicka
Organizations
- University of Louisville